Outsee

Using AI based predictive genomics for drug target discovery

Outsee

Outsee is a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery. OutSee’s proprietary Nomaly technology predicts disease and phenotype ab initio directly from a single genome. Unlike other methods commonly used for target discovery, the AI-powered engine uses hypothesis-free, predictive modelling to draw conclusions from the fundamental molecular and cellular biology of the genome, rather than by pattern-matching known genetic associations.

Key People

Prof. Julian Gough
Prof. Chang Lu

Domain

Genetics & Platform Technologies

prev page Nu Quantum next page Ovo Labs

We use cookies to give you the best experience on our website. Learn more.

accept